BrightPath Capital’s most common sectors for investment are apparel/textiles (34%) and life science (34%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (100%). In total, BrightPath Capital has invested in 3 US states. Its largest (disclosed) acquisition occurred in 2011 when it acquired Grand River Aseptic Manufacturing for $5M.
In the last 3 years, BrightPath Capital has exited 2 companies. The Firm’s most common exit type is trade sale (50%).
Join Mergr to view BrightPath Capital’s full profile and discover more small private equity firms just like it.
BrightPath Capital, Inc. is a private equity firm that targets investments in small to mid-sized businesses. BrightPath will consider opportunities across the US, however the Firm primarily focuses on companies in the Midwest. Target businesses generally possess recurring/predictable cash-flows, low technology risk, strong/defensible market positions, and proven management. The Firm looks to invest $1 to $5 million in companies with at least $3 million in revenues and $500,000 in EBITDA. BrightPath is a generalist investor, however the Firm will not invest in high tech, retail, and restaurants. Prospective transaction types include MBOs, growth financings, acquisition financings, and recapitalizations. BrightPath Capital was formed in 2005 and is based in Indianapolis, Indiana.
Join Mergr to view the latest updates and news from Indianapolis-based BrightPath Capital.
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.